Sanofi (SNY) Acquisitions (2023 - 2026)

Sanofi has disclosed Acquisitions across 4 years of filings, most recently posting -$2.0 billion for Q1 2026.

• In Q1 2026, Acquisitions changed N/A year-over-year to -$2.0 billion; the TTM figure through Mar 2026 stood at -$17.6 billion (changed N/A YoY), while the FY2025 annual figure was -$12.8 billion, down 371.29% from the prior year.
• Acquisitions came in at -$2.0 billion for Q1 2026 at Sanofi, up from -$12.8 billion in the prior quarter.
• In the past five years, Acquisitions ranged from a high of -$90.2 million in Q1 2024 to a low of -$12.8 billion in Q4 2025.
• Average Acquisitions over 4 years is -$4.2 billion, with a median of -$2.7 billion recorded in 2024.
• Year-over-year, Acquisitions advanced 20.87% in 2024 and slumped 376.97% in 2025.
• Over 4 years, Acquisitions stood at -$3.4 billion in 2023, then increased by 20.87% to -$2.7 billion in 2024, then tumbled by 376.97% to -$12.8 billion in 2025, then surged by 84.41% to -$2.0 billion in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were -$2.0 billion in Q1 2026, -$12.8 billion in Q4 2025, and -$2.7 billion in Q4 2024.